NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Homopeptide? Mail in a sample (US only) and let us test it.

Test my supply
+5 more ↓
58%
Finnrick rating
#458 of 500 ranked vendors
26 of 38 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Homopeptide's purity-focus record is strongest for Retatrutide, where a relatively deep series mostly returned high purity after one sharp miss, though fills have swung. Tirzepatide includes a severe identity/purity/fill failure, Tesamorelin remains mixed, and KPV is consistently weak; sparse batch IDs keep batch-level certainty limited.

methodology →
vendor intelligence report
Vendor Intelligence Report: Homopeptide

Fresh verifier-like domains, a self-contained web-infrastructure loop, and an unverified Janoshik trail complicate Homopeptide’s public trust story. The report maps the corporate anchor, rotating contacts, reported Airtm payment path, warehouse claims, and impersonation evidence.

26 pages6 risk factors assessed2 Jul 2026
read the report
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%1 Jan 2026: 80%15 Jan 2026: 62%4 Feb 2026: 63%11 Feb 2026: 53%11 Feb 2026: 54%6 Mar 2026: 54%18 Mar 2026: 60%18 Mar 2026: 63%25 Mar 2026: 64%28 Apr 2026: 64%28 Apr 2026: 64%28 Apr 2026: 64%28 Apr 2026: 64%28 Apr 2026: 64%28 Apr 2026: 65%28 Apr 2026: 64%1 Jun 2026: 65%16 Jun 2026: 65%24 Jun 2026: 65%1 Jul 2026: 66%13 Jul 2026: 65%15 Jul 2026: 65%20 Jul 2026: 65%3 Aug 2026: 66%4 Aug 2026: 56%4 Aug 2026: 57%4 Aug 2026: 57%5 Aug 2026: 58%4 Sep 2026: 58%16 Sep 2026: 57%16 Sep 2026: 56%21 Sep 2026: 55%24 Sep 2026: 56%24 Sep 2026: 56%12 Oct 2026: 55%12 Oct 2026: 55%12 Oct 2026: 56%6 Nov 2026: 56%17 Nov 2026: current 58%80%64%58%Jan 26Nov 26
Peptide testing

Ordered peptides from Homopeptide? Mail in a sample (US only) and let us test it.

Test my supply
Homopeptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
6 Nov 2026
Pass
Retatrutide
lab nameView COA
12 Oct 2026
Pass
Tirzepatide
lab nameView COA
12 Oct 2026
Fail
Tirzepatide
lab nameView COA
12 Oct 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Pass
Tirzepatide
lab nameView COA
21 Sep 2026
Fail
Tirzepatide
lab nameView COA
16 Sep 2026
Fail
Retatrutide
lab nameView COA
16 Sep 2026
Fail
BPC-157
lab nameView COA
4 Sep 2026
Fail
KPV
lab nameView COA
1-10 of 38

About Homopeptide test results from Finnrick

Homopeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 38 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Homopeptide peptides in this dataset are BPC-157 (5 tests), KPV (3 tests) and Retatrutide (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 38 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Homopeptide? Mail in a sample (US only) and let us test it.

Test my supply